Product: Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03)  Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA.
Reason for recall: Presence of Particulate Matter: Silicone oil
Recall initiated: 20170726
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated